Home > Insider Trading > Filing (0001171843-16-013396)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1370820	Matthias Alder	805 King Farm Blvd, Suite 550 Rockville MD 20850	Evp, Bus. Dev.&Lic, G.c. &Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Class A	Acquisiton	2016-11-23	26,000	$8.33	29,449	No	4	M	Direct
Common Stock, Class A	Disposition	2016-11-23	26,000	$15.77	3,449	No	4	S	Direct
Common Stock, Class A	Acquisiton	2016-11-25	99,025	$8.33	102,474	No	4	M	Direct
Common Stock, Class A	Disposition	2016-11-25	99,025	$15.88	3,449	No	4	S	Direct
Common Stock, Class A	Acquisiton	2016-11-28	24,975	$8.33	28,424	No	4	M	Direct
Common Stock, Class A	Disposition	2016-11-28	24,975	$16.73	3,449	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2016-11-23	26,000	$0.00	26,000	$8.33
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2016-11-25	99,025	$0.00	99,025	$8.33
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2016-11-28	24,975	$0.00	24,975	$8.33

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
386,500	2024-10-27	No	4	M	Direct
287,475	2024-10-27	No	4	M	Direct
262,500	2024-10-27	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.65 to $15.88, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.20, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.15 to $17.45, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range.
62,996 options became exercisable on 10/27/15, and 62,996 options became exercisable on 10/27/16.